1 Innis SM (2005) Essential fatty acid transfer and fetal development. Placenta 26, S70–S75.
2 Van Houwelingen AC, Sorensen JD, Hornstra G, et al. (1995) Essential fatty acid status in neonates after fish-oil supplementation during late pregnancy. Br J Nutr 74, 723–731.
3 Elias SL & Innis SM (2001) Infant plasma trans, n-6, and n-3 fatty acids and conjugated linoleic acids are related to maternal plasma fatty acids, length of gestation, and birth weight and length. Am J Clin Nutr 73, 807–814.
4 Decsi T, Campoy C & Koletzko B (2005) Effect of N-3 polyunsaturated fatty acid supplementation in pregnancy: the Nuheal trial. Adv Exp Med Biol 569, 109–113.
5 Krauss-Etschmann S, Shadid R, Campoy C, et al. (2007) Effects of fish-oil and folate supplementation of pregnant women on maternal and fetal plasma concentrations of docosahexaenoic acid and eicosapentaenoic acid: a European randomized multicenter trial. Am J Clin Nutr 85, 1392–1400.
6 Koletzko B, Larque E & Demmelmair H (2007) Placental transfer of long-chain polyunsaturated fatty acids (LCPUFA). J Perinat Med 35, Suppl 1, S5–11.
7 Larque E, Krauss-Etschmann S, Campoy C, et al. (2006) Docosahexaenoic acid supply in pregnancy affects placental expression of fatty acid transport proteins. Am J Clin Nutr 84, 853–861.
8 Olsen SF, Hansen HS, Sorensen TI, et al. (1986) Intake of marine fat, rich in (n-3) polyunsaturated fatty acids, may increase birthweight by prolonging gestation. Lancet 2, 367–369.
9 Olsen SF (2004) Is supplementation with marine omega-3 fatty acids during pregnancy a useful tool in the prevention of preterm birth? Clin Obstet Gynecol 47, 768–774.
10 Heird WC & Lapillonne A (2005) The role of essential fatty acids in development. Annu Rev Nutr 25, 549–571.
11 Hadders-Algra M, Bouwstra H, van Goor SA, et al. (2007) Prenatal and early postnatal fatty acid status and neurodevelopmental outcome. J Perinat Med 35, Suppl 1, S28–S34.
12 McCann JC & Ames BN (2005) Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals. Am J Clin Nutr 82, 281–295.
13 Uauy R & Dangour AD (2006) Nutrition in brain development and aging: role of essential fatty acids. Nutr Rev 64, S24–S33.
14 Hibbeln JR, Ferguson TA & Blasbalg TL (2006) Omega-3 fatty acid deficiencies in neurodevelopment, aggression and autonomic dysregulation: opportunities for intervention. Int Rev Psychiatry 18, 107–118.
15 Innis SM (2007) Dietary (n-3) fatty acids and brain development. J Nutr 137, 855–859.
16 Schuchardt JP, Huss M, Stauss-Grabo M, et al. (2010) Significance of long-chain polyunsaturated fatty acids (PUFAs) for the development and behaviour of children. Eur J Pediatr 169, 149–164.
17 Clandinin MT, Chappell JE, Leong S, et al. (1980) Extrauterine fatty acid accretion in infant brain: implications for fatty acid requirements. Early Hum Dev 4, 131–138.
18 Martinez M (1992) Tissue levels of polyunsaturated fatty acids during early human development. J Pediatr 120, S129–S138.
19 Innis SM (2009) Omega-3 Fatty acids and neural development to 2 years of age: do we know enough for dietary recommendations? JPGN 48, Suppl 1, S16–S24.
20 Williams C, Birch EE, Emmett PM, et al. (2001) Stereoacuity at age 3.5 y in children born full-term is associated with prenatal and postnatal dietary factors: a report from a population-based cohort study. Am J Clin Nutr 73, 316–322.
21 Innis SM, Gilley J & Werker J (2001) .
22 Hibbeln JR, Davis JM, Steer C, et al. (2007) Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): an observational cohort study. Lancet 369, 578–585.
23 Koletzko B, Lien E, Agostoni C, et al. (2008) The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. J Perinat Med 36, 5–14.
24 Gibson RA, Muhlhausler B & Makrides M (2011) Conversion of linoleic acid and alpha-linolenic acid to long-chain polyunsaturated fatty acids (LCPUFAs), with a focus on pregnancy, lactation and the first 2 years of life. Maternal & Child Nutrition 7, 17–26.
25 Delgado-Noguera MF, Calvache JA & Bonfill C (2010) Supplementation with long chain polyunsaturated fatty acids (LCPUFA) to breastfeeding mothers for improving child growth and development. Cochrane Database Syst Rev CD007901.
26 Dziechciarz P, Horvath A & Szajewska H (2010) Effects of n-3 long-chain polyunsaturated fatty acid supplementation during pregnancy and/or lactation on neurodevelopment and visual function in children: a systematic review of randomized controlled trials. J Am Coll Nutr 29, 443–454.
27 Makrides M, Collins CT & Gibson RA (2011) Impact of fatty acid status on growth and neurobehavioural development in humans. Matern Child Nutr 7, Suppl 2, 80–88.
28 Uauy RD, Birch DG, Birch EE, et al. (1990) Effect of dietary n-3 fatty acids on retinal function of very low birthweight neonates. Pediatr Research 28, 485–492.
29 Birch DG, Birch EE, Hoffman DR, et al. (1992) Retinal development in very-low-birth-weight infants fed diets differing in omega-3 fatty acids. Invest Ophthalmol Vis Sci 33, 2365–2376.
30 Carlson SE, Werkman SH, Rhodes PG, et al. (1993) Visual-acuity development in healthy preterm infants: effect of marine-oil supplementation. Am J Clin Nutr 58, 35–42.
31 Makrides M, Simmer K, Goggin M, et al. (1993) Erythrocyte docosahexaenoic acid correlates with the visual response of the healthy, term infant. Pediatr Res 33, 3242–3253.
32 Agostoni C, Trojan S, Bellu R, et al. (1997) Developmental quotient at 24 months and fatty acid composition of diet in early infancy: a follow up study. Arch Dis Child 76, 421–424.
33 Lucas A, Stafford M, Morley R, et al. (1999) Efficacy and safety of long-chain polyunsaturated fatty acid supplementation of infant formula milk: a randomised trial. Lancet 354, 1948–1954.
34 Hoffman DR, Birch EE, Birch DG, Wheaton DH, et al. (2000) Impact of early dietary intake and blood lipid composition of long-chain polyunsaturated fatty acids on later visual development. JPGN 31, 540–553.
35 Morrow-Tlucak M, Haude RH & Ernhart CB (1988) Breastfeeding and cognitive development in the first two years of life. Social Science & Medicine 26, 635–639.
36 Uauy R, Hoffman DR, Mena P, et al. (2003) Term infant studies of DHA and ARA supplementation on neurodevelopment: results of randomized controlled trials. J Pediatr 143, 4, S17–S25.
37 Uauy R (1990) Are omega-3 fatty acids required for normal eye and brain development in the human? J Pediatr Gastroenterol Nutr 11, 296–302.
38 Caspi A, Williams B, Kim-Cohen J, et al. (2007) Moderation of breastfeeding effects on the IQ by genetic variation in fatty acid metabolism. Proc Natl Acad Sci U S A 104, 18860–18865.
39 Steer CD, Smith DG, Emmett PM, et al. (2010) FADS2 Polymorphisms Modify the Effect of Breastfeeding on Child IQ. PLoS ONE 5, e11570.
40 Anderson RE, Maude MB, Alvarez RA, et al. (1999) A hypothesis to explain the reduced blood levels of docosahexaenoic acid in inherited retinal degenerations caused by mutations in genes encoding retina-specific proteins. Lipids 34, S235–S237.
41 Robinson KA & Dickersin K (2002) Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed. International Journal of Epidemiology 31, 150–153.
42 Horvath A, Koletzko B & Szajewska H (2007) Effect of supplementation of women in high-risk pregnancies with long-chain polyunsaturated fatty acids on pregnancy outcomes and growth measures at birth: a meta-analysis of randomized controlled trials. Br J Nutr 98, 253–259.
43 Szajewska H, Horvath A A & Koletzko B (2006) Effect of n-3 long-chain polyunsaturated fatty acid supplementation of women with low-risk pregnancies on pregnancy outcomes and growth measures at birth: a meta-analysis of randomized controlled trials. Am J Clin Nutr 83, 1337–1344.
44 Beyerlein A, Hadders-Algra M, Kennedy K, et al. (2010) Infant formula supplementation with long-chain polyunsaturated fatty acids has no effect on Bayley developmental scores at 18 months of age–IPD meta-analysis of 4 large clinical trials. J Pediatr Gastroenterol Nutr 50, 79–84.
45 Simmer K, Patole SK & Rao SC (2008) Longchain polyunsaturated fatty acid supplementation in infants born at term. Cochrane Database Syst Rev CD000376.
46 Blau-Hospers CH & Hadders-Algra M (2005) Developmental Medicine & Child Neurology 47, 421–432.
47 Makrides M, Duley L & Olsen SF (2006) Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction. Cochrane Database Syst Rev 3, CD003402.
48 Dunstan JA, Simmer K, Dixon G, et al. (2008) Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 93, F45–F50.
49 Malcolm CA, Hamilton R, McCulloch DL, et al. (2003 b) Scotopic electroretinogram in term infants born of mothers supplemented with docosahexaenoic acid during pregnancy. Invest Ophthalmol Vis Sci 44, 3685–3691.
50 Malcolm CA, McCulloch DL, Montgomery C, et al. (2003 a) Maternal docosahexaenoic acid supplementation during pregnancy and visual evoked potential development in term infants: a double blind, prospective, randomised trial. Arch Dis Child Fetal Neonatal Ed 88, F383–F390.
51 Innis SM & Friesen RW (2008) Essential n-3 fatty acids in pregnant women and early visual acuity maturation in term infants. Am J Clin Nutr 87, 548–557.
52 Judge MP, Harel O & Lammi-Keefe CJ (2007 a) A docosahexaenoic acid-functional food during pregnancy benefits infant visual acuity at four but not six months of age. Lipids 42, 117–122.
53 Judge MP, Harel O & Lammi-Keefe CJ (2007 b) Maternal consumption of a docosahexaenoic acid-containing functional food during pregnancy: benefit for infant performance on problem-solving but not on recognition memory tasks at age 9 mo. Am J Clin Nutr 85, 1572–1577.
54 Tofail F, Kabir I, Hamadani JD, et al. (2006) Supplementation of fish-oil and soy-oil during pregnancy and psychomotor development of infants. J Health Popul Nutr 24, 48–56.
55 Escolano-Margarit MV, Ramos R, Beyer J, et al. (2011) Prenatal DHA Status and Neurological Outcome in Children at Age 5.5 Years Are Positively Associated. J Nutr 141, 1216–1223.
56 Campoy C, Escolano-Margarit MV & Ramos R (2011) Effects of prenatal fish oil and 5-methyltetrahidrofolate supplementation on cognitive development of children at 6 ½ years of age. Am J Clin Nutr .
57 Olsen SF, Sorensen JD, Secher NJ, et al. (1992) Randomised controlled trial of effect of fish-oil supplementation on pregnancy duration. Lancet 339, 1003–1007.
58 Ramakrishnan U, Stein AD, Parra-Cabrera S, et al. (2010) Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double-blind, placebo-controlled trial in Mexico. Food Nutr Bull 31, S108–S116.
59 Courville AB, Harel O & Lammi-Keefe CJ (2011) Consumption of a DHA-containing functional food during pregnancy is associated with lower infant ponderal index and cord plasma insulin concentration. Br J Nutr 27, 1–5.
60 Smuts CM, Borod E, Peeples JM, et al. (2003 a) High-DHA eggs: feasibility as a means to enhance circulating DHA in mother and infant. Lipids 38, 407–414.
61 Smuts CM, Huang M, Mundy D, et al. (2003 b) A randomized trial of docosahexaenoic acid supplementation during the third trimester of pregnancy. Obstet Gynecol 469, 479.
62 Stein AD, Wang M, Martorell R, et al. (2011) Growth to Age 18 Months Following Prenatal Supplementation with Docosahexaenoic Acid Differs by Maternal Gravidity in Mexico. J Nutr 141, 316–320.
63 Sanjurjo P, Ruiz-Sanz JI, Jimeno P, et al. (2004) Supplementation with docosahexaenoic acid in the last trimester of pregnancy: maternal-fetal biochemical findings. J Perinat Med 32, 132–136.
64 Makrides M, Gibson RA, McPhee AJ, et al. (2010) Effect of DHA Supplementation During Pregnancy on Maternal Depression and Neurodevelopment of Young Children A Randomized Controlled Trial. JAMA 304, 1675–1683.
65 Smithers LG, Gibson RA & Makrides M (2011) Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. Am J Clin Nutr 93, 1293–1299.
66 Helland IB, Saugstad OD, Smith L, et al. (2001) Similar effects on infants of n-3 and n-6 fatty acids supplementation to pregnant and lactating women. Pediatrics 108, E82–E95.
67 Helland IB, Smith L, Saarem K, et al. (2003) Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age. Pediatrics 111, e39–e44.
68 Helland IB, Smith L, Blomen B, et al. (2008) Effect of supplementing pregnant and lactating mothers with n-3 very-long-chain fatty acids on children's IQ and body mass index at 7 years of age. Pediatrics 122, e472–e479.
69 Bergmann LR, Bergmann KE, Haschke-Becher E, et al. (2007) Does maternal docosahexaenoic acid supplementation during pregnancy and lactation lower BMI in late infancy. J Perinat Med 35, 295–300.
70 Jensen CL, Voigt RG, Prager TC, et al. (2005) Effects of maternal docosahexaenoic acid intake on visual function and neurodevelopment in breastfed term infants. Am J Clin Nutr 82, 125–132.
71 Lauritzen L, Jorgensen MH, Mikkelsen TB, et al. (2004) Maternal fish oil supplementation in lactation: effect on visual acuity and n-3 fatty acid content of infant erythrocytes. Lipids 39, 195–206.
72 Lauritzen L, Jørgensen MH, Olsen SF, et al. (2005) Maternal fish oil supplementation in lactation: effect on developmental outcome in breast-fed infants. Reprod Nutr Dev 45, 535–547.
73 Cheatham CL, Nerhammer AS, Asserhoj M, et al. (2011) Fish oil supplementation during lactation: effects on cognition and behavior at 7 years of age. Lipids 46, 637–645.
74 Jensen CL, Voigt RG, Llorente AM, et al. (2010) Effects of early maternal docosahexaenoic acid intake on neuropsychological status and visual acuity at five years of age of breast-fed term infants. J Pediatr 157, 900–905.
75 Drover JR, Hoffman DR, Castaneda YS, et al. (2011) Cognitive function in 18-month-old term infants of the DIAMOND study: a randomized, controlled clinical trial with multiple dietary levels of docosahexaenoic acid. Early Hum Dev 87, 223–230.
76 Birch EE, Carlson SE, Hoffman DR, et al. (2010) The DIAMOND (DHA Intake And Measurement Of Neural Development) Study: a double-masked, randomized controlled clinical trial of the maturation of infant visual acuity as a function of the dietary level of docosahexaenoic acid. Am J Clin Nutr 91, 848–859.
77 De Jong C, Kikkert HK, Fidler V, et al. (2010) The Groningen LCPUFA study: no effect of postnatal long-chain polyunsaturated fatty acids in healthy term infants on neurological condition at 9 years. Br J Nutr 104, 566–572.
78 Birch EE, Garfield S, Castaneda Y, et al. (2007) Visual acuity and cognitive outcomes at 4 years of age in a double-blind, randomized trial of long-chain polyunsaturated fatty acid-supplemented infant formula. Early Hum Dev 83, 279–284.
79 Bouwstra H, Dijck-Brouwer DA, Boehm G, et al. (2005) Acta Paediatr 94, 26–32.
80 Auestad N, Scott DT, Janowsky JS, et al. (2003) Visual, cognitive, and language assessments at 39 months: a follow-up study of children fed formulas containing long-chain polyunsaturated fatty acids to 1 year of age. Pediatrics 112, e177–e183.
81 Lucas A, Morley R, Stephenson T, et al. (2002) Long-chain polyunsaturated fatty acids and infant formula. Lancet 360, 1178–1185.
82 Agostoni C, Riva E, Scaglioni S, et al. (2000) Dietary fats and cholesterol in Italian infants and children. Am J Cli Nutr 72, 1384S–1391S.
83 Birch EE, Garfield S, Hoffman DR, et al. (2000) A randomised controlled trial of early dietary supply of LCPUFA and mental development in term infants. Dev Med Child Neurol 42, 174–181.
84 Makrides M, Neumann MA, Simmer K, et al. (2000) A appraisal of the role of long-chain polyunsaturated fatty acids on neural indices of term infants: a randomised controlled trial. Pediatrics 105, 32–38.
85 Makrides M, Neumann MA, Simmer K, et al. (1999) Dietary long chain polyunsaturated fatty acids do not influence growth of term infants: a randomised clinical trial. Pediatrics 104, 468–475.
86 Birch EE, Hoffman DR, Uauy R, et al. (1998) Visual acuity and the essentiality of docosahexaenoic acid and arachidonic acid in the diet of term infants. Pediatr Res 44, 201–209.
87 Scott DT, Janowsky JS, Carroll RE, et al. (1998) Formula supplementation with long-chain polyunsaturated fatty acids: are there developmental benefits? Pediatrics 102, e59.
88 Auestad N, Montalto MB, Hall RT, et al. (1997) Visual acuity, erythrocyte fatty acid composition, and growth in term infants fed formulas with long-chain polyunsaturated fatty acids for one year. Ped Res 41, 1–10.
89 Agostoni C, Trojan S, Bellu R, et al. (1995) Neurodevelopmental quotient of healthy term infants at 4 months and feeding practice: the role of long-chain polyunsaturated fatty acids. Ped Res 38, 262–266.
90 Birch EE, Castañeda Y, Wheaton DH, et al. (2005) Visual maturation of term infants fed long-chain polyunsaturated fatty acid-supplemented or control formula for 12 mo. Am J Clin Nutr 81, 871–879.
91 Ben XM, Zhou XY, Zhao WH, et al. (2004) Growth and development of term infants fed with milk with long-chain polyunsaturated fatty acid supplementation. Chinese Medical Journal 117, 1268–1270.
92 Auestad N, Halter R, Hall RT, et al. (2001) Growth and development in term infants fed long-chain polyunsaturated fatty acids: a double-masked, randomized, parallel, prospective, multivariate study. Pediatrics 108, 372–381.
93 Lapillonne A, Brosssard N, Claris O, et al. (2000) Erythrocyte fatty acid composition in term infants fed human milk or a formula enriched with a low eicosapentanoic acid fish oil for 4 months. European Journal of Pediatrics 159, 49–53.
94 Morris G, Moorcraft J, Mountjoy A, et al. (2000) A novel infant formula milk with added long-chain polyunsaturated fatty acids from single-cell sources: a study of growth, satisfaction and health. Eur J Clin Nutr 54, 883–886.
95 Willatts P, Forsyth JS, DiModugno MK, et al. (1998) Effect of long-chain polyunsaturated fatty acids in infant formula on problem solving at 10 months of age. Lancet 352, 688–691.
96 Carlson SE, Ford AJ, Werkman SH, et al. (1996) Visual acuity and fatty acid status of term infants fed human milk and formulas with and without docosahexaenoate and arachidonate from egg yolk lecithin. Ped Res 39, 882–888.
97 Makrides M, Neumann M, Simmer K, et al. (1995) Pater J, Gibson R. Are long chain polyunsaturated fatty acids essential nutrients in infancy? Lancet 345, 1463–1468.
98 Makrides M (2008) Outcomes for mothers and their babies: do n-3 long-chain polyunsaturated fatty acids and seafoods make a difference? J Am Diet Assoc 108, 1622–1626.
99 Hibbeln JR, Davis JM, Steer C, et al. (2007) Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): an observational cohort study. Lancet 369, 578–585.
100 Dangour AD & Uauy R (2008) N-3 long-chain polyunsaturated fatty acids for optimal function during brain development and ageing. Asia Pac J Clin Nutr 17, Suppl 1, 185–188.
101 Koletzko B, Agostoni C, Carlson SE, et al. (2001) Long chain polyunsaturated fatty acids (LCPUFA) and perinatal development. Acta Paediatr 90, 460–464.
102 Lattka E, Eggers S, Moeller G, et al. (2010) A common FADS2 promoter polymorphism increases promoter activity and facilitates binding of transcription factor ELK1. J Lipid Res 51, 182–191.
103 Glaser C, Lattka E, Rzehak P, et al. (2011) Genetic variation in polyunsaturated fatty acid metabolism and its potential relevance for human development and health. Matern Child Nutr 7, Suppl 2, 27–40.
104 Koletzko B, Lattka E, Zeilinger S, et al. (2011) Genetic variants of the fatty acid desaturase gene cluster predict amounts of red blood cell docosahexaenoic and other polyunsaturated fatty acids in pregnant women: findings from the Avon Longitudinal Study of Parents and Children. Am J Clin Nutr 93, 211–219.
105 Burgard P (2003) Critical evaluation of the methodology employed in cognitive development trials. Acta Paediatr Suppl 92, 6–10.
106 Schmitt JA, Benton D & Kallus KW (2005) General methodological considerations for the assessment of nutritional influences on human cognitive functions. Eur J Nutr 44, 459–464.
107 Hughes D & Bryan J (2003) The Assessment of Cognitive Performance in Children: Considerations for Detecting Nutritional Influences. Nutrition Reviews 61, 413–422.
108 Tomas Paus (2010) A primer for brain imaging: a tool for evidence-based studies of nutrition? Nutrition Reviews 68, Suppl 1, S29–S37.